GlassScriptPhysician profile
Jacqueline Anh Koichi
NPI 1952988982
$3,226.76
in general payments reported to CMS, 2019-2025
15 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $157 · 2023: $1,098 · 2024: $1,590 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,069.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,644.11 | 2023-2025 | Vraylar |
| Otsuka America Pharmaceutical, INC. | $471.53 | 2023-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Neurocrine Biosciences, INC. | $216.93 | 2023-2025 | Ingrezza |
| Janssen Pharmaceuticals, INC | $146.06 | 2023-2024 | Invega Sustenna |
| Alkermes, INC. | $144.49 | 2022-2024 | Aristada, Lybalvi |
| Teva Pharmaceuticals USA, INC. | $141.05 | 2022-2025 | Austedo Xr, Uzedy |
| Lundbeck LLC | $127.04 | 2023-2024 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $78.14 | 2024 | Caplyta |
| Ironshore Pharmaceuticals INC. | $77.68 | 2023-2024 | Jornay Pm |
| Axsome Therapeutics, INC. | $54.14 | 2023 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $41.65 | 2023-2024 | Trintellix |
| Vanda Pharmaceuticals INC. | $29.95 | 2023 | Hetlioz, Fanapt |
| Tris Pharma INC | $19.32 | 2024 | Dyanavel Xr |
| Amneal Pharmaceuticals LLC | $18.89 | 2022 | |
| Kyowa Kirin, INC. | $15.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Koichi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.